Healthcare Sector Review: Top Winning and Losing Stocks

Wall St. Watchdog reveals information about today’s action in the Healthcare sector (NYSE:XLV):

Gainer (% price change)

  • Cornerstone Therapeutics (NASDAQ:CRTX): The shares closed at $7.48, up $0.84, or 12.65%, on the day. Its market capitalization is $194.15 million. About the company: Cornerstone Therapeutics, Inc. is a biopharmaceutical company that discovers, develops, and commercializes therapeutic products. The Company develops products that are designed to regulate the body’s inflammatory response associated with asthma and critical care diseases, and products for the respiratory market.
  • DepoMed, Inc. (NASDAQ:DEPO): The shares closed at $6.33, up $0.68, or 12.04%, on the day. Its market capitalization is $350.45 million. About the company: DepoMed, Inc. develops new and proprietary oral drug delivery technologies. The Company has developed a system designed to be retained in the stomach for an extended period of time while it delivers the incorporated drug or drugs. DepoMed has also developed a system designed to reduce gastrointestinal irritation.
  • Alnylam Pharmaceuticals (NASDAQ:ALNY): The shares closed at $7.25, up $0.67, or 10.18%, on the day. Its market capitalization is $309.23 million. About the company: Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes.
  • Endologix, Inc. (NASDAQ:ELGX): The shares closed at $10.05, up $0.9, or 9.84%, on the day. Its market capitalization is $578.06 million. About the company: Endologix, Inc. develops, manufactures, sells, and markets minimally invasive treatments for vascular diseases. The Company’s products include the Powerlink System, a catheter-based endoluminal stent graft that treats abdominal aortic aneurysms. Endologix’s products are sold in the United States as well as international markets.
  • Alphatec Holdings, Inc. (NASDAQ:ATEC): The shares closed at $2.54, up $0.22, or 9.48%, on the day. Its market capitalization is $226.63 million. About the company: Alphatec Holdings, Inc. manufactures medical devices. The Company produces products for the surgical treatment of spinal disorders. Alphatec manufactures spine screws, spinal spacers, and plates.

Loser (% price change)

  • InterMune, Inc. (NASDAQ:ITMN): The shares closed at $24.20, down $2.67, or 9.94%, on the day. Its market capitalization is $1.47 billion. About the company: InterMune, Inc. is a biopharmaceutical company. The Company develops therapies for hepatology and pulmonology, including treatments for severe, malignant osteopetrosis and chronic granulomatous disease
  • Pharmaceutical Product (NASDAQ:PPDI): The shares closed at $28.59, down $0.92, or 3.12%, on the day. Its market capitalization is $3.26 billion. About the company: Pharmaceutical Product Development, Inc. (NYSE:PPD) offers drug discovery and development services to pharmaceutical, biotechnology, and medical device companies. The Company conducts pre-clinical programs and phase I to phase IV clinical trials. For approved drugs, PPD offers product launch services, and patient compliance and medical communications programs.
  • SuperGen, Inc. (NASDAQ:SUPG): The shares closed at $2.03, down $0.06, or 2.87%, on the day. Its market capitalization is $188.35 million. About the company: SuperGen, Inc. is a pharmaceutical company that acquires, develops, and markets products for the treatment of life-threatening diseases, particularly cancer. The Company is marketing Nipent in the United States for the treatment of hairy cell leukemia. SuperGen is also conducting late stage clinical trials on a drug that has the potential to treat a variety of solid tumors.
  • Amarin Corp. plc (NASDAQ:AMRN): The shares closed at $10.25, down $0.3, or 2.84%, on the day. Its market capitalization is $1.36 billion. About the company: Amarin Corporation PLC is a clinical-stage biopharmaceutical company. The Company researches, develops, and commercializes drugs for the treatment of hypertriglyceridemia, central nervous system disorders, and cardiovascular diseases.
  • Vical Incorporated (NASDAQ:VICL): The shares closed at $3.27, down $0.09, or 2.68%, on the day. Its market capitalization is $234.91 million. About the company: Vical Incorporated develops gene-based pharmaceutical products for human therapy. The Company develops cancer product candidates, as well as develops vaccines for infectious diseases and gene-based delivery of therapeutic proteins for other disorders.

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet